The DOI matches its Crossref record; 152 of the 155 references it cites were found in a registry or an index.
Monocyte-Macrophages and T Cells in Atherosclerosis
Open accessAbstract
Atherosclerosis is an arterial disease process characterized by the focal subendothelial accumulation of apolipoprotein-B-containing lipoproteins, immune and vascular wall cells, and extracellular matrix. The lipoproteins acquire features of damage-associated molecular patterns and trigger first an innate immune response, dominated by monocyte-macrophages, and then an adaptive immune response. These inflammatory responses often become chronic and non-resolving and can lead to arterial damage and thrombosis-induced organ infarction. The innate immune response is regulated at various stages, from hematopoiesis to monocyte changes and macrophage activation. The adaptive immune response is regulated primarily by mechanisms that affect the balance between regulatory and effector T cells. Mechanisms related to cellular cholesterol, phenotypic plasticity, metabolism, and aging play key roles in affecting these responses. Herein, we review select topics that shed light on these processes and suggest new treatment strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Immunosuppressive drug regimens may have adverse effects on lipid metabolism leading to increases in TC, VLDL, and TGs, and in the size and density of LDL particles.”
From 2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk (2019) · cites this paper as [502]
In the citing paper
“These effects vary with different immunosuppressive drugs [497,498,502-506].”
From 2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk (2019) · cites this paper as [502]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
Ridker, P. M., Everett, B. M., Thuren, T., MacFadyen, J. G., Chang, W. H., Ballantyne, C., Fonseca, F., Nicolau, J., Koenig, W., Anker, S. D., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1707914 · Cited by 9,482
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
Wang, Z., Klipfell, E., Bennett, B. J., Koeth, R., Levison, B. S., DuGar, B., Feldstein, A. E., Britt, E. B., Fu, X., Chung, Y.-M., et al. (2011) · Nature · doi:10.1038/nature09922 · Cited by 5,597
Lusis, A. J. (2000) · Nature · doi:10.1038/35025203 · Cited by 4,880
Age-related clonal hematopoiesis associated with adverse outcomes
Jaiswal, S., Fontanillas, P., Flannick, J., Manning, A., Grauman, P. V., Mar, B. G., Lindsley, R. C., Mermel, C. H., Burtt, N., Chavez, A., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1408617 · Cited by 4,841
Cytokine-mediated regulation of CXCR4 expression in human neutrophils
Nagase, H., Miyamasu, M., Yamaguchi, M., Imanishi, M., Tsuno, N. H., Matsushima, K., Yamamoto, K., Morita, Y., & Hirai, K. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.71.4.711 · Cited by 4,713
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
Duewell, P., Kono, H., Rayner, K. J., Sirois, C. M., Vladimer, G., Bauernfeind, F. G., Abela, G. S., Franchi, L., Nuñez, G., Schnurr, M., et al. (2010) · Nature · doi:10.1038/nature08938 · Cited by 4,026 · cited 1×
“Although cholesterol crystals have been implicated in this process (Duewell et al., 2010; Sheedy et al., 2013), other mechanisms are likely to contribute as well (Hoseini et al., 2017).”
Glass, C. K., & Witztum, J. L. (2001) · Cell · doi:10.1016/s0092-8674(01)00238-0 · Cited by 3,094
Trained immunity: A program of innate immune memory in health and– disease
Netea, M. G., Joosten, L. A. B., Latz, E., Mills, K. H. G., Natoli, G., Stunnenberg, H. G., O’Neill, L. A. J., & Xavier, R. J. (2016) · Science · doi:10.1126/science.aaf1098 · Cited by 2,768
Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease
Jaiswal, S., Natarajan, P., Silver, A. J., Gibson, C. J., Bick, A. G., Shvartz, E., McConkey, M., Gupta, N., Gabriel, S., Ardissino, D., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1701719 · Cited by 2,683
Lakatta, E. G., & Levy, D. (2003) · Circulation · doi:10.1161/01.cir.0000048892.83521.58 · Cited by 2,244
Flagged first, then by citations
3 of the 155 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 201–300 of 650
Driving T cells to human atherosclerotic plaques: CCL3/CCR5 and CX3CL1/CX3CR1 migration axes
Komissarov, A. A., Potashnikova, D. M., Freeman, M. L., Gontarenko, V., Maytesyan, D., Lederman, M. M., Vasilieva, E., & Margolis, L. B. (2021) · European Journal of Immunology · doi:10.1002/eji.202049004 · Cited by 29
Cholesterol Acceptors Regulate the Lipidome of Macrophage Foam Cells
Paul, A., Lydic, T. A., Hogan, R., & Goo, Y. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20153784 · Cited by 28
A Novel Macrophage Subpopulation Conveys Increased Genetic Risk of Coronary Artery Disease
Jiang, J., Hiron, T. K., Agbaedeng, T. A., Malhotra, Y., Drydale, E., Bancroft, J. M., Ng, E., Reschen, M. E., Davison, L. J., & O’Callaghan, C. A. (2024) · Circulation Research · doi:10.1161/circresaha.123.324172 · Cited by 32
Geng, S., Lu, R., Zhang, Y., Wu, Y., Xie, L., Caldwell, B. A., Pradhan, K., Yi, Z., Hou, J., Xu, F., et al. (2024) · Circulation Research · doi:10.1161/circresaha.124.325023 · Cited by 30
Butyrate mitigates TNF-α-induced attachment of monocytes to endothelial cells
Wang, Y., Xu, Y., Mao, Y., Zhang, M., Xiao, M., & Li, X. (2020) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-020-09841-9 · Cited by 28
Metabolic regulation of immune cells in proinflammatory microenvironments and diseases during ageing
Li, P., Zhang, R., Cheng, L., Liu, J., & Chen, H. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101165 · Cited by 29
Immune Cell Landscape of Patients With Diabetic Macular Edema by Single-Cell RNA Analysis
Ma, P., Zhang, P., Chen, S., Shi, W., Ye, J., Chen, S., Ju, R., Liu, B., Zheng, Y., & Liu, Y. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.754933 · Cited by 28
Decano, J. L., & Aikawa, M. (2018) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2018.00097 · Cited by 29
Zheng, Z., Li, K., Yang, Z., Wang, X., Shen, C., Zhang, Y., Lu, H., Yin, Z., Sha, M., Ye, J., et al. (2024) · Inflammation Research · doi:10.1007/s00011-024-01877-6 · Cited by 31
Polyunsaturated Fatty Acids and Atherosclerosis: Insights from Pre‐Clinical Studies
Ramji, D. P. (2018) · European Journal of Lipid Science and Technology · doi:10.1002/ejlt.201800029 · Cited by 28
Liao, Y., Zhu, E., & Zhou, W. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.697236 · Cited by 27
Therapeutic Strategies and Chemoprevention of Atherosclerosis: What Do We Know and Where Do We Go?
Aprotosoaie, A. C., Costache, A. D., & Costache, I. I. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14040722 · Cited by 29
Liu, Q., Pan, J., Bao, L., Xu, C., Qi, Y., Jiang, B., Wang, D., Zhu, X., Li, X., Zhang, H., et al. (2022) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.121.316662 · Cited by 27
Manickam, V., Dhawan, U. K., Singh, D., Gupta, M., & Subramanian, M. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.888300 · Cited by 28
Recent progress of endoplasmic reticulum stress in the mechanism of atherosclerosis
Ni, L., Yang, L., & Lin, Y. (2024) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2024.1413441 · Cited by 32
Schwab, R. D., Degaramo, D. A., Hong, S. J., Bi, X., Faruqi, A., Aguilar, W., Brookens, S. K., Keane, J. T., Liu, F., Musunuru, K., et al. (2025) · Circulation · doi:10.1161/circulationaha.125.073987 · Cited by 29
Zhang, Y., Xu, H., Yu, F., Wang, M., Li, M., Xu, T., Gao, Y., Wang, J., & Li, P. (2018) · PPAR Research · doi:10.1155/2018/8530371 · Cited by 27
The immune functions of PCSK9: Local and systemic perspectives
Liu, X., Suo, R., Chan, C. Z. Y., Liu, T., Tse, G., & Li, G. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28612 · Cited by 26
Design of selective cell migration biomaterials and their applications for tissue regeneration
Cui, Y., Yang, Y., & Qiu, D. (2020) · Journal of Materials Science · doi:10.1007/s10853-020-05537-y · Cited by 26
SNF5 promotes IL-1β expression via H3K4me1 in atherosclerosis induced by homocysteine
Xie, L., Ding, N., Zhang, H., Liu, K., Xiong, J., Ma, S., Yang, A., Zhang, H., & Jiang, Y. (2021) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2021.105974 · Cited by 26
Sun, Y., Long, J., Chen, W., Sun, Y., Zhou, L., Zhang, L., Zeng, H., & Yuan, D. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107956 · Cited by 26
Mathematical modeling of inflammatory processes of atherosclerosis
Younes, G. A., & Khatib, N. E. (2022) · Mathematical Modelling of Natural Phenomena · doi:10.1051/mmnp/2022004 · Cited by 26
Khan, I., Khan, I., Usman, M., Jianye, Z., Wei, Z. X., Ping, X., Li, Z., & An, L. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.943808 · Cited by 25
Ewert, L., Fischer, A., Brandt, S., Scurt, F. G., Philipsen, L., Müller, A. J., Girndt, M., Zenclussen, A. C., Lindquist, J. A., Gorny, X., et al. (2018) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2018.09.020 · Cited by 25
Liver‐humanized mice: A translational strategy to study metabolic disorders
Luo, Y., Lu, H., Peng, D., Ruan, X., Chen, Y. E., & Guo, Y. (2021) · Journal of Cellular Physiology · doi:10.1002/jcp.30610 · Cited by 27
Liu, J., Guo, Z., Zhang, Y., Wu, T., Ma, Y., Lai, W., & Guo, Z. (2020) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2020.01.003 · Cited by 24
Busnelli, M., Manzini, S., Chiara, M., Colombo, A., Fontana, F., Oleari, R., Potì, F., Horner, D. S., Bellosta, S., & Chiesa, G. (2020) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.120.315669 · Cited by 24
Profiles of Immune Cell Infiltration in Carotid Artery Atherosclerosis Based on Gene Expression Data
Wang, L., Gao, B., Wu, M., Yuan, W., Liang, P., & Huang, J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.599512 · Cited by 24
Huang, H., Chen, Z., Li, Y., Gong, K., Xiao, L., Fu, H., Yang, J., Wang, X., & Meng, Q. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/6497568 · Cited by 24
Li, B., Liu, Y., Zhang, L., Guo, X., Wen, C., Zhang, F., Luo, X., & Xia, Y. (2021) · The FASEB Journal · doi:10.1096/fj.202100695rr · Cited by 24
Degradable co-delivery nanoplatforms for inflammation-targeted therapy against atherosclerosis
Wu, Z., Xu, Z., Pu, H., Li, W., Liu, J., Zhao, Z., Lu, X., Lin, K., & Li, B. (2021) · Applied Materials Today · doi:10.1016/j.apmt.2021.101214 · Cited by 24
Analysis of Immune and Inflammation Characteristics of Atherosclerosis from Different Sample Sources
NIE, H., Chen, Y., Zhou, W., & Li, T. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/5491038 · Cited by 24
Nguyen, H. N., Ahn, Y. J., Medina, E. A., & Asmis, R. (2018) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2018.06.882 · Cited by 24
miRNA‐mediated macrophage behaviors responding to matrix stiffness and ox‐LDL
Li, J., Wang, S., Li, Y., Zhang, N., Gribskov, M., Zhang, X., Lin, M., Shao, D., Zhang, C., Dai, L., et al. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29543 · Cited by 24
A novel strategy to dissect multifaceted macrophage function in human diseases
Karlinsey, K., Qu, L., Matz, A. J., & Zhou, B. (2022) · Journal of Leukocyte Biology · doi:10.1002/jlb.6mr0522-685r · Cited by 23
Liaqat, A., Asad, M., Shoukat, F., & Khan, A. (2020) · Inflammation · doi:10.1007/s10753-020-01290-1 · Cited by 25
Huan, W., Liu, Y., Wang, C., Sili, Z., Jun, B., MingFang, L., Chen, Y., & Qu, L. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.752773 · Cited by 23
The blood microbiome and its association to cardiovascular disease mortality: case-cohort study
Lawrence, G., Midtervoll, I., Samuelsen, S. O., Kristoffersen, A. K., Enersen, M., & Håheim, L. L. (2022) · BMC Cardiovascular Disorders · doi:10.1186/s12872-022-02791-7 · Cited by 23
Blood Monocyte Phenotype Is A Marker of Cardiovascular Risk in Type 2 Diabetes
Julla, J., Girard, D., Diedisheim, M., Saulnier, P., Vuong, T. B., Blériot, C., Carcarino, E., Keizer, J. D., Orliaguet, L., Nemazanyy, I., et al. (2023) · Circulation Research · doi:10.1161/circresaha.123.322757 · Cited by 24
Amersfoort, J., Douna, H., Schaftenaar, F. H., Foks, A. C., Kröner, M. J., van Santbrink, P. J., van Puijvelde, G. H. M., Bot, I., & Kuiper, J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02937 · Cited by 23
Zeng, Z., Cao, B., Guo, X., Li, W., Li, S., Chen, J., Zhou, W., Zheng, C., & Wei, Y. (2018) · Europe PMC (PubMed Central) · Cited by 23
CircARCN1 aggravates atherosclerosis by regulating HuR-mediated USP31 mRNA in macrophages
Pan, Z., Lv, J., Zhao, L., Xing, K., Ye, R., Zhang, Y., Chen, S., Yang, P., Yu, H., Lin, Y., et al. (2024) · Cardiovascular Research · doi:10.1093/cvr/cvae148 · Cited by 22
Monocyte Single-Cell Multimodal Profiling in Cardiovascular Disease Risk States
Bashore, A. C., Xue, C., Kim, E., Yan, H., Zhu, L. Y., Pan, H., Kissner, M. D., Ross, L. S., Zhang, H., Li, M., et al. (2024) · Circulation Research · doi:10.1161/circresaha.124.324457 · Cited by 26
Ma, C., Hua, Y., Yang, S., Zhao, Y., Zhang, W., Miao, Y., Zhang, J., Feng, B., Zheng, G., Li, L., et al. (2025) · Advanced Science · doi:10.1002/advs.202500610 · Cited by 22
Hu, H., Zhang, S., & Pan, S. (2021) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.1c01445 · Cited by 23
Comprehensive Analysis to Identify Key Genes Involved in Advanced Atherosclerosis
Huo, T.-M., & Wang, Z. (2021) · Disease Markers · doi:10.1155/2021/4026604 · Cited by 22
Surface-modified nanotherapeutics targeting atherosclerosis
Li, W., Gonzalez, K. M., Chung, J., Kim, M., & Lu, J. (2022) · Biomaterials Science · doi:10.1039/d2bm00660j · Cited by 22
Li, H., Zhao, L., Li, Q., Huang, L., Qin, Y., Zhuang, Z., Wang, X., Huang, H., Zhang, J., Zhang, J., et al. (2023) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2023.108971 · Cited by 22
Villa, F., Carrizzo, A., Ferrario, A., Maciag, A. E., Cattaneo, M., Spinelli, C., Montella, F., Damato, A., Ciaglia, E., & Puca, A. A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19103229 · Cited by 22
Atherosclerosis as an inflammatory disease: Doubts? No more
Vaccarezza, M., Balla, C., & Rizzo, P. (2018) · IJC Heart & Vasculature · doi:10.1016/j.ijcha.2018.03.003 · Cited by 22
Xu, B., Xiao, L., Kang, C., Ding, L., Guo, F., Li, P., Lu, Z., Wu, Q., Xu, Y., Bai, H., et al. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28650 · Cited by 21
Lee‐Rueckert, M., Lappalainen, J., Leinonen, H., Plihtari, R., Nordström, T., Åkerman, K. E. O., Öörni, K., & Kovanen, P. T. (2020) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2020.08.011 · Cited by 21
Gao, X., Liu, Y., Tian, Y., Rao, C., Shi, F., Bu, H., Liu, J., Zhang, Y., Shan, W., Ding, Z., et al. (2021) · Journal of International Medical Research · doi:10.1177/03000605211010059 · Cited by 21
Cabou, C., & Martinez, L. O. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23115883 · Cited by 21
Macrophage efferocytosis in atherosclerosis
Baraniecki, Ł., Tokarz–Deptuła, B., Syrenicz, A., & Deptuła, W. (2022) · Scandinavian Journal of Immunology · doi:10.1111/sji.13251 · Cited by 21
Irie, K., Azuma, T., Tomofuji, T., & Yamamoto, T. (2023) · Dentistry Journal · doi:10.3390/dj11080194 · Cited by 24
Rožman, P. J. (2018) · GeroScience · doi:10.1007/s11357-018-0027-x · Cited by 20
Sun, Y., Guan, J., Hou, Y., Xue, F., Huang, W. C., Zhang, W., Zhang, Y., Zhang, C., & Yang, J. (2019) · Clinical Science · doi:10.1042/cs20180561 · Cited by 21
Anti-inflammatory Therapies for Cardiovascular Disease: Signaling Pathways and Mechanisms
Martínez‐Hervás, S., & Navarro, H. G. (2019) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2019.03.007 · Cited by 22
Senotherapeutics for HIV and aging
Szaniawski, M. A., & Spivak, A. M. (2019) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000609 · Cited by 23
Lestari, S. R., Atho’illah, M. F., Christina, Y. I., & Rifa’i, M. (2020) · Journal of Ayurveda and Integrative Medicine · doi:10.1016/j.jaim.2020.06.009 · Cited by 21
Zinc finger E‐box binding homeobox 1 and atherosclerosis: New insights and therapeutic potential
Li, H., Zou, J., Yu, X., Ou, X., & Tang, C. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.30177 · Cited by 20
Lappalainen, J., Yeung, N., Nguyen, S. D., Jauhiainen, M., Kovanen, P. T., & Lee‐Rueckert, M. (2021) · Scientific Reports · doi:10.1038/s41598-021-84249-y · Cited by 20
Prognostic Value of Multiple Complete Blood Count-Derived Indices in Intermediate Coronary Lesions
Yang, Y., Song, C., Jia, L., Dong, Q., Song, W., Yin, D., & Dou, K. (2023) · Angiology · doi:10.1177/00033197231198678 · Cited by 20
Mangione, M. C., Wen, J., & Cao, D. J. (2023) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2023.10.011 · Cited by 20
Multipathway Regulation for Targeted Atherosclerosis Therapy Using Anti-miR-33-Loaded DNA Origami
Ma, Y., Wang, Q., Du, S., Luo, J., Sun, X., Jia, B., Ge, J., Dong, J., Jiang, S., & Li, Z. (2024) · ACS Nano · doi:10.1021/acsnano.3c10213 · Cited by 20
Long Noncoding RNAs of the Arterial Wall as Therapeutic Agents and Targets in Atherosclerosis
Holdt, L. M., Kohlmaier, A., & Teupser, D. (2019) · Thrombosis and Haemostasis · doi:10.1055/s-0039-1692680 · Cited by 20
Li, M., Xie, Z., Cai, Z., Su, F., Guan, Z., Li, J., Wang, S., Cen, S., Liu, W., Tang, S., et al. (2019) · Stem Cell Research & Therapy · doi:10.1186/s13287-019-1306-x · Cited by 19
Andújar, I., Esplugues, J. V., & García-Martínez, P. (2022) · Pharmaceuticals · doi:10.3390/ph15091101 · Cited by 19
Wang, P., Chen, Z., & Xing, D. (2020) · Optics Express · doi:10.1364/oe.390874 · Cited by 19
Nogieć, A., Bzowska, M., Demczuk, A., Varol, C., & Guzik, K. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01592 · Cited by 21
Filippov, M. A., Tatarnikova, O. G., Pozdnyakova, N. V., & Vorobyov, V. (2020) · Neural Regeneration Research · doi:10.4103/1673-5374.290878 · Cited by 21
ACE2 Is an Adjacent Element of Atherosclerosis and COVID-19 Pathogenesis
Poznyak, A. V., Bezsonov, E. E., Eid, A. H., Попкова, Т. В., Недосугова, Л. В., Starodubova, A. V., & Orekhov, A. N. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094691 · Cited by 19
Anti‐inflammatory effects of natural products from vitamin C‐rich fruits
Chan, S., Xiong, P., Zhao, M., Zhang, S., Zheng, R.-B., Ye, J., Chan, K. I., Li, C., & Zhong, Z. (2024) · Food Frontiers · doi:10.1002/fft2.433 · Cited by 19
Dicks, L. M. T. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26146744 · Cited by 22
Membrane-permeabilized sonodynamic therapy enhances drug delivery into macrophages
Cao, Z., Zhang, T., Sun, X., Liu, M., Shen, Z., Li, B., Zhao, X., Jin, H. H., Zhang, Z., & Tian, Y. (2019) · PLoS ONE · doi:10.1371/journal.pone.0217511 · Cited by 18
Li, Z., Ma, D., Wang, Y., Wu, S., Wang, L., Jiang, Y., Zhang, Y., & Li, X. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/7421265 · Cited by 18
Deleting interleukin-10 from myeloid cells exacerbates atherosclerosis in Apoe−/− mice
Orecchioni, M., Wolf, D., Suryawanshi, V., Winkels, H., Kobiyama, K., Makings, J., Kiosses, W. B., & Ley, K. F. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04649-9 · Cited by 18
Abubakar, M., Rasool, H. F., Javed, I., Raza, S., Abang, L., Hashim, M. M. A., Saleem, Z., Abdullah, R. M., Faraz, M. A., Hassan, K. M., et al. (2023) · Cureus · doi:10.7759/cureus.42494 · Cited by 18
Zhao, W., Li, B., Hao, J., Sun, R., He, P., Lv, H., He, M., Shen, J., & Han, Y. (2024) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2024.108652 · Cited by 18
Prenatal inflammation exposure-programmed cardiovascular diseases and potential prevention
Deng, Y., Song, L., Nie, X., Shou, W., & Li, X. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.05.009 · Cited by 18
Li, X., Lu, Z., Zhou, F., Jin, W., Yang, Y., Chen, S., Xie, Z., & Zhao, Y. (2020) · Vascular Pharmacology · doi:10.1016/j.vph.2020.106763 · Cited by 18
Hao, Y., Wang, X., Zhang, F., Wang, M., Wang, Y., Wang, H., Du, Y., Wang, T., Fu, F., Gao, Z., et al. (2020) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2020.115211 · Cited by 18
Immune-Inflammation in Atherosclerosis: A New Twist in an Old Tale
Talepoor, A. G., Fouladseresht, H., Khosropanah, S., & Doroudchi, M. (2019) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530319666191016095725 · Cited by 16
Anti-inflammatory Treatment and Cardiovascular Outcomes: Results of Clinical Trials
Lorenzatti, A. J. (2021) · European Cardiology Review · doi:10.15420/ecr.2020.51 · Cited by 17
Joshi, C., Bapat, R. A., Anderson, W., Dawson, D. K., Cherukara, G., & Hijazi, K. (2021) · Journal Of Clinical Periodontology · doi:10.1111/jcpe.13550 · Cited by 17
Wang, L., Huang, S., Liang, X., Zhou, J.-L., Han, Y., He, J., & Xu, D. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1377470 · Cited by 17
Development of Pro-resolving and Pro-efferocytic Nanoparticles for Atherosclerosis Therapy
Patel, Y., Manturthi, S., Tiwari, S., Gahunia, E., Courtemanche, A., Gandelman, M., Côté, M., & Gadde, S. (2024) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.4c00292 · Cited by 18
Cardiovascular oncology: exploring the effects of targeted cancer therapies on atherosclerosis
Seijkens, T. T. P., & Lutgens, E. (2018) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000538 · Cited by 17
Flow cytometric identification and cell-line establishment of macrophages in naked mole-rats
Wada, H., Shibata, Y., Abe, Y., Otsuka, R., Eguchi, N., Kawamura, Y., Oka, K., Baghdadi, M., Atsumi, T., Miura, K., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-54442-1 · Cited by 21
Expression analysis of inflammatory response-associated genes in coronary artery disease
Ebadi, N., Ghafouri‐Fard, S., Taheri, M. N., Arsang‐Jang, S., & Omrani, M. D. (2020) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2019.1708953 · Cited by 17
Mycobacterium bovis Bacille-Calmette-Guérin Infection Aggravates Atherosclerosis
Huaman, M. A., Qualls, J. E., Jose, S., Schmidt, S., Moussa, A., Kuhel, D. G., Konaniah, E. S., Komaravolu, R. K., Fichtenbaum, C. J., Deepe, G. S., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.607957 · Cited by 17
Pradhan, K., Geng, S., Zhang, Y., Lin, R., & Li, L. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.2000978 · Cited by 17
The Combined Regulation of Long Non-coding RNA and RNA-Binding Proteins in Atherosclerosis
Ding, Y., Yin, R., Zhang, S., Xiao, Q., Zhao, H., Pan, X., & Zhu, X. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.731958 · Cited by 17
Gao, S., Wang, X., Cheng, D., Li, J., Li, L., Ran, L., Zhao, S., Fan, J., & Liu, E. (2017) · Mediators of Inflammation · doi:10.1155/2017/3824276 · Cited by 17
Bo, M., Arru, G., Niegowska, M., Erre, G. L., Manchia, P., & Sechi, L. A. (2019) · Microorganisms · doi:10.3390/microorganisms7100423 · Cited by 18
Collura, S., Morsiani, C., Vacirca, A., Fronterrè, S., Ciavarella, C., Vasuri, F., D’Errico, A., Franceschi, C., Pasquinelli, G., Gargiulo, M., et al. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101090 · Cited by 17
Recent Advances on the Role and Therapeutic Potential of Regulatory T Cells in Atherosclerosis
Tanaka, T., Sasaki, N., & Rikitake, Y. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10245907 · Cited by 18
Ge, P., Li, H., Ya, X., Xu, Y., Ma, L., He, Q., Wang, R., Liu, Z., Zhang, Q., Zhang, Y., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1085468 · Cited by 16
Huang, H., Ren, P., Zhao, Y., Weng, H., Jia, C., Yu, F., & Nie, Y. (2023) · Tissue and Cell · doi:10.1016/j.tice.2023.102043 · Cited by 16
Metadata
- Authors
- Tabas, I., & Lichtman, A. H.
- Affiliations
- Columbia University Irving Medical Center (US)
- Brigham and Women's Hospital (US)
- Corresponding author
- Tabas, Ira
- Lichtman, Andrew H.
- Venue
- Immunity
- Publisher
- Elsevier BV
- Published
- 2017-10
- Volume
- 47
- Issue
- 4
- Pages
- 621-634
- ISSN
- 1074-7613 (ISSN-L)
- PMC
- PMC5747297
- OpenAlex
- W2766451938
- Cited by
- 646
- References
- 155
- Citations by year
- 2026: 53 · 2025: 57 · 2024: 72 · 2023: 65 · 2022: 86 · 2021: 102 · 2020: 80 · 2019: 78 · 2018: 49 · 2017: 4
- FWCI
- 6.01
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Immunity (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- NIH (R01 HL132412, HL127464, HL075662, P01 HL087123, R01 HL087282, HL131862)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Keywords
- atherosclerosis, monocytes/macrophages, T cells, innate immune response, adaptive immune response, damage-associated molecular patterns, apolipoprotein B-containing lipoproteins, macrophage activation, regulatory T cells, effector T cells, chronic inflammation, thrombosis, hematopoiesis, cholesterol, phenotypic plasticity, aging, atherosclerosis treatment
- MeSH terms
- Animals, Humans, Immunity, Innate, Lipoproteins, Macrophages, Monocytes, T-Lymphocytes, Models, Immunological, Atherosclerosis, Adaptive Immunity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
